Pharmaceutical giant Gilead Sciences has agreed to donate drugs that reduce the risk of HIV transmission for up to 200,000 people a year, the Trump administration says.
The agreement between Gilead and the Trump administration will last until at least Dec. 31, 2025, and possibly through the end of 2030, Health and Human Services Secretary Alex Azar said in a statement Thursday. Gilead will donate its PrEP medication Truvada, which is used to reduce the risk of HIV infection and usually sells for $1,600 to $2,000 a month in the United States.
The deal will “help us achieve our goal of ending the HIV epidemic in America!,” President Donald Trump said in a tweet.
About the Author
I couldn't agree with you more! Everything work pretty good until developers decided every rich guy needed a house on…
It was a conservative MAGA lover who spear headed this. Not everything is the libs fault. Open borders? Libs. Ridiculous…
Housing should be safe and stable — period. I’m sorry residents are dealing with this, and I hope the right…
Have you ever tried walking on those big rocks? I have and I don't recommend it. It's actually dangerous.
I must add this, it's not just racism, and really it's not that at all. Before you hate on me…